Printer Friendly

DRUGDEX System Written Into U.S. Code as Reference Compendium.

DENVER--(BW HealthWire)--Oct. 20, 1997--For the first time ever, the DRUGDEX(R) System has been written into the U.S. Code as a reference compendium for drug use review required under Subchapter XIX, "Grants to States for Medical Assistance Programs."

DRUGDEX is recommended to be used as another standard by which states can evaluate outpatient drug use to ensure that prescriptions are appropriate, medically necessary and are not likely to result in adverse medical results. In the program, DRUGDEX joins the ranks of widely accepted sources such as the American Hospital Formulary Service Drug Information.

"The inclusion of DRUGDEX gives states efficient, immediate access to the most comprehensive source of drug information when medications are prescribed for off-label uses," said Michael Cohen, president of the Institute for Safe Medication Practices. "As this legislation greatly expands the potential for off-label drug use for Medicaid patients, DRUGDEX ensures that the medications are prescribed appropriately and accurately so that patients accrue optimal benefit from their availability."

"The inclusion of DRUGDEX in Federal Code is, in effect, the U.S. government's endorsement of our data's universal acceptance and impeccability," said Nancy Sayre, senior vice president, healthcare products, MICROMEDEX. "To my knowledge, this is the first time that a private company's drug information system has been included as a reference standard in code of this nature."

Introduced in 1979, DRUGDEX delivers unbiased drug information for healthcare professionals who prescribe, order, dispense or administer medications, and offers a wide range of information related to drug therapy in the clinical setting.

Headquartered in Denver, Colo., MICROMEDEX is a member of the Thomson Healthcare Information Group and a world renowned provider of the most comprehensive decision support databases available, with knowledge bases in more than 3,000 facilities in 90 countries. -0-

Note to Editors: HCFA release available upon request. More information about MICROMEDEX is available on the World Wide Web at http://www.micromedex.com.

CONTACT: SMC-Falcone

Kassy McGourty, 908/713-1267
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 20, 1997
Words:325
Previous Article:Solucorp Enters into $US 10 Million Chinese Joint Venture; Company Triples Production Capacity as Result of Agreement.
Next Article:Servico Acquires Comfort Inn Roseville, Minnesota.
Topics:


Related Articles
ERGOLOID MESYLA.TES (HYDERGINE).
Medication Update. (Featured CME Topic: Hypertension).
Desmopressin (DDAVP). (Medication Update).
George Duncan's effort for Kennedy Information garners a 325 percent ROI--and a Gold Award from NL/NL. (Promotion).
Craftsman's Contruction Intallation Encyclopedia.
Compendium of the Social Doctrine of the Church (Religion).
When Writing Workshop Isn't Working.
The Erotic Writer's Market Guide.
The Erotic Writer's Market Guide.
New On The Job.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters